RYTM
Rhythm Pharmaceuticals Inc
88.50$
-2.6%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +682.9% | +275.2% | +76.8% | -17.6% | +505.2% | -52.7% | +105.2% | +30.5% | +67.6% | +17.1% | +7.7% | +7.2% | +12.0% | +14.4% | +25.8% | -21.8% | +48.3% | +5.8% | +11.6% | +5.0% | +18.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +3,325.0% | +62.0% | +6.3% | -2.5% | +64.3% | +31.5% | +106.8% | +38.2% | +57.4% | +7.9% | +34.0% | -13.2% | +5.0% | +29.9% | -1.1% | -3.7% | +51.9% | -0.8% | -12.7% | +49.0% | +24.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +341.9% | +488.3% | +96.2% | -19.8% | +585.2% | -56.4% | +105.0% | +29.5% | +69.0% | +18.3% | +4.5% | +10.3% | +12.8% | +12.6% | +29.3% | -23.6% | +47.8% | +6.6% | +14.5% | +1.0% | +17.7% | – | |
| – | +3.9% | -13.5% | +10.8% | +10.6% | +11.4% | +84.7% | -30.1% | +24.7% | +75.3% | +21.3% | +55.1% | -24.7% | -6.6% | -9.3% | +2.2% | 0.0% | -4.5% | -9.3% | +26.1% | +9.7% | +14.7% | +3.0% | -3.2% | -32.9% | +11.5% | +61.1% | -11.6% | +0.1% | -11.0% | +329.8% | -76.6% | +26.4% | +8.5% | -10.2% | +14.4% | +8.8% | -8.7% | -0.7% | +4.1% | – | |
| – | +179.4% | +130.9% | +5.8% | -65.4% | +87.0% | +8.9% | +36.5% | +32.7% | -1.8% | -7.5% | +13.9% | +19.2% | -10.6% | +35.9% | -30.3% | +26.5% | +13.3% | +2.5% | +17.9% | +13.2% | +19.9% | +2.2% | +4.1% | -1.7% | +20.0% | -6.4% | +22.0% | +1.4% | +6.2% | +6.2% | +5.9% | -2.9% | +7.8% | +2.5% | +17.6% | +14.1% | +9.6% | +10.6% | +6.1% | – | |
| – | +30.8% | -23.7% | +5.7% | +22.7% | +32.5% | +54.8% | -11.6% | +28.1% | +41.1% | +12.4% | +44.7% | -16.0% | -7.8% | +3.1% | -9.6% | +7.4% | +2.3% | -1.8% | +17.8% | +11.0% | +16.7% | +2.6% | -0.3% | -20.0% | +15.8% | +25.5% | +1.6% | +0.7% | -2.8% | +161.9% | -59.1% | +10.1% | +8.2% | -4.1% | +16.0% | +11.6% | +1.1% | +5.8% | +5.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -37.0% | +4,560.9% | +40.4% | +1.7% | +7.9% | -4.7% | +44.5% | +4.5% | -3.2% | +13.9% | +3.9% | -0.7% | +7.5% | -18.5% | -2.7% | -0.7% | -0.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -161.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +3,504.2% | -103.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | -122.8% | – | – | – | -219.2% | – | -75.6% | -190.5% | – | +348.8% | -46.7% | +53.1% | +59.7% | -171.8% | – | – | +321.3% | -67.1% | -127.9% | – | -18.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -180.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.